{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:17:17Z","timestamp":1769638637004,"version":"3.49.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1053\/j.semperi.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T17:05:52Z","timestamp":1353603952000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment and Prophylaxis of Invasive Candidiasis"],"prefix":"10.1053","volume":"36","author":[{"given":"Nidhi","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2012.06.003_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in neonatal intensive care unit patients","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00006454-200006000-00002","article-title":"Systemic Candida infection in extremely low birth weight infants: Short term morbidity and long term neurodevelopmental outcome","volume":"19","author":"Friedman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1542\/peds.101.4.654","article-title":"Candida sepsis and association with retinopathy of prematurity","volume":"101","author":"Mittal","year":"1998","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00181784","article-title":"Systemic candidiasis in babies with retinopathy of prematurity","volume":"230","author":"Kremer","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1053\/j.semperi.2012.06.003_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006454-199509000-00009","article-title":"Neonatal Candida parapsilosis outbreak with a high case fatality rate","volume":"14","author":"Saxen","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.95.5.682","article-title":"Invasive fungal dermatitis in the \u22641000-gram neonate","volume":"95","author":"Rowen","year":"1995","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib9","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1542\/peds.2009-3412","article-title":"Neonatal candidiasis: Epidemiology, risk factors, and clinical judgment","volume":"126","author":"Benjamin","year":"2010","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.78.2.225","article-title":"Fungal colonization in the very low birth weight infant","volume":"78","author":"Baley","year":"1986","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(05)81375-7","article-title":"Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates","volume":"124","author":"Rowen","year":"1994","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib12","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1515\/JPM.2007.055","article-title":"Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit","volume":"35","author":"Manzoni","year":"2007","journal-title":"J Perinat Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1542\/peds.2006-1311","article-title":"Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization","volume":"118","author":"Manzoni","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00006454-199807000-00004","article-title":"Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants","volume":"17","author":"Fanaroff","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.jp.7211068","article-title":"Mortality following blood culture in premature infants: Increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia","volume":"24","author":"Benjamin","year":"2004","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2012.06.003_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00006454-200009000-00003","article-title":"Persistently positive cultures and outcome in invasive neonatal candidiasis","volume":"19","author":"Chapman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/INF.0b013e3181920ffd","article-title":"Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: Comparison of mortality and costs","volume":"28","author":"Moran","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1542\/peds.112.3.634","article-title":"Neonatal candidemia and end-organ damage: A critical appraisal of the literature using meta-analytic techniques","volume":"112","author":"Benjamin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an elevated dosage of micafungin in premature neonates","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/clpt.2009.200","article-title":"Safety and pharmacokinetics of repeat-dose micafungin in young infants","volume":"87","author":"Benjamin","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semperi.2012.06.003_bib24","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/INF.0b013e3182127eaf","article-title":"Safety of micafungin in pediatric clinical trials","volume":"30","author":"Arrieta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/524063","article-title":"The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: Implications for echinocandin therapy in neonates","volume":"197","author":"Hope","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib26","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/AAC.39.9.2128","article-title":"Resistance of Candida albicans biofilms to antifungal agents in vitro","volume":"39","author":"Hawser","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/318473","article-title":"Candida lusitaniae: A cause of breakthrough fungemia in cancer patients","volume":"32","author":"Minari","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jac\/dkg419","article-title":"Treatment of candidaemia in premature infants: Comparison of three amphotericin B preparations","volume":"52","author":"Linder","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-003-0993-4","article-title":"High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates","volume":"22","author":"Juster-Reicher","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0022-3476(05)82674-5","article-title":"Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates","volume":"116","author":"Baley","year":"1990","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib32","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1128\/AAC.49.12.5092-5098.2005","article-title":"Population pharmacokinetics of amphotericin B lipid complex in neonates","volume":"49","author":"W\u00fcrthwein","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(02)00066-2","article-title":"A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates","volume":"238","author":"Kotwani","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1053\/j.semperi.2012.06.003_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02113589","article-title":"Multifocal osteoarthritis due to Candida albicans in a neonate: Serum level monitoring of liposomal amphotericin B and literature review","volume":"25","author":"Evdoridou","year":"1997","journal-title":"Infection"},{"key":"10.1053\/j.semperi.2012.06.003_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF01974619","article-title":"Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents","volume":"13","author":"Fasano","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0002-9343(99)80148-X","article-title":"Fatal acute hepatic necrosis due to fluconazole","volume":"99","author":"Chmel","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(94)90141-4","article-title":"Fatal acute hepatic necrosis due to fluconazole","volume":"96","author":"Jacobson","year":"1994","journal-title":"Am J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archinte.1991.00400050150032","article-title":"Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome","volume":"151","author":"Mu\u0144oz","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib39","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/516975","article-title":"Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity","volume":"25","author":"Bronstein","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0163-4453(92)91346-D","article-title":"Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge","volume":"24","author":"Wells","year":"1992","journal-title":"J Infect"},{"key":"10.1053\/j.semperi.2012.06.003_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00006454-199612000-00011","article-title":"Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: A prospective randomized trial","volume":"15","author":"Driessen","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib44","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","article-title":"Population pharmacokinetics of fluconazole in young infants","volume":"52","author":"Wade","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/INF.0b013e318202cbb3","article-title":"Fluconazole loading dose pharmacokinetics and safety in infants","volume":"30","author":"Piper","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0732-8893(98)00160-6","article-title":"Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States","volume":"33","author":"Pfaller","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib47","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/JCM.37.11.3735-3737.1999","article-title":"Candida isolates from neonates: Frequency of misidentification and reduced fluconazole susceptibility","volume":"37","author":"Rowen","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.semperi.2012.06.003_bib48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JCM.40.3.852-856.2002","article-title":"Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.semperi.2012.06.003_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/648679","article-title":"Voriconazole pharmacokinetics and pharmacodynamics in children","volume":"50","author":"Neely","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.jp.7211532","article-title":"Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight","volume":"26","author":"Frankenbusch","year":"2006","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2012.06.003_bib52","first-page":"236","article-title":"Voriconazole in newborns","volume":"45","author":"Kohli","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib53","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/01.inf.0000095167.38306.76","article-title":"Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection","volume":"22","author":"Maples","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1592\/phco.2005.25.6.893","article-title":"Intravenous voriconazole therapy in a preterm infant","volume":"25","author":"Muldrew","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.semperi.2012.06.003_bib55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.inf.0000258698.98370.89","article-title":"Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin","volume":"26","author":"Santos","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib56","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/INF.0b013e31824acc33","article-title":"Therapeutic monitoring of voriconazole in children less than 3 years of age: A case report and summary of voriconazole concentrations for 10 children","volume":"31","author":"Doby","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.00751-08","article-title":"Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies","volume":"53","author":"Karlsson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-009-0296-3","article-title":"Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders","volume":"89","author":"Ueda","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1053\/j.semperi.2012.06.003_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib60","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/588844","article-title":"Hallucinations during voriconazole therapy","volume":"47","author":"Zonios","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib61","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/clinids\/6.6.791","article-title":"Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis","volume":"6","author":"Smego","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(87)90691-7","article-title":"Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis","volume":"83","author":"Stamm","year":"1987","journal-title":"Am J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib63","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jac\/dkl550","article-title":"Flucytosine therapeutic monitoring: 15 years experience from the UK","volume":"59","author":"Pasqualotto","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib64","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.41.11.2326","article-title":"In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)","volume":"41","author":"Bartizal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","author":"Walker","year":"2010","journal-title":"Fungal Genet Biol"},{"key":"10.1053\/j.semperi.2012.06.003_bib66","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":"The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.00868-08","article-title":"Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age","volume":"53","author":"S\u00e1ez-Llorens","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib68","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/AAC.01027-08","article-title":"Pharmacokinetics and safety of caspofungin in older infants and toddlers","volume":"53","author":"Neely","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib69","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib70","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0091270004265644","article-title":"Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal","volume":"44","author":"Dowell","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.semperi.2012.06.003_bib71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270006297227","article-title":"Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment","volume":"47","author":"Dowell","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.semperi.2012.06.003_bib72","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/AAC.01279-08","article-title":"In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin","volume":"53","author":"Damle","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib73","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/clpt.2011.26","article-title":"Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates","volume":"89","author":"Cohen-Wolkowiez","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semperi.2012.06.003_bib74","unstructured":"Vehreschild J, M\u00fcller C, Farowski F, et al: Pharmacokinetics of prophylactic posaconazole. Presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, 2011, Chicago, IL"},{"key":"10.1053\/j.semperi.2012.06.003_bib75","unstructured":"Krishna G, Ma L, Martinho M, et al: Posaconazole multiple dose pharmacokinetic and safety in healthy volunteers from a new solid oral tablet formulation. Presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, 2011, Chicago, IL"},{"key":"10.1053\/j.semperi.2012.06.003_bib76","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib77","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10096-010-0957-4","article-title":"Posaconazole salvage treatment in paediatric patients: A multicentre survey","volume":"29","author":"Lehrnbecher","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/AAC.44.2.441-443.2000","article-title":"In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B","volume":"44","author":"Moore","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib79","first-page":"555","article-title":"Ravuconazole (Eisai\/Bristol-Myers Squibb)","volume":"3","author":"Arikan","year":"2002","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1053\/j.semperi.2012.06.003_bib80","unstructured":"Olsen SJ, Mummaneni V, Rolan P, et al: Ravuconazole Single Ascending Oral Dose Study in Healthy Subjects [abstract no. 838]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2000, September 17-20, Toronto"},{"key":"10.1053\/j.semperi.2012.06.003_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000048580","article-title":"Penetration of ravuconazole, a new triazole antifungal, into rat tissues","volume":"48","author":"Mikamo","year":"2002","journal-title":"Chemotherapy"},{"key":"10.1053\/j.semperi.2012.06.003_bib82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(88)80069-6","article-title":"A randomized, controlled trial of parenteral clindamycin in neonatal necrotizing enterocolitis","volume":"112","author":"Faix","year":"1988","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib83","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","article-title":"Potential drug sequestration during extracorporeal membrane oxygenation: Results from an ex vivo experiment","volume":"33","author":"Mehta","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00134-008-1269-3","article-title":"Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation","volume":"35","author":"Ruiz","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/dkp026","article-title":"Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation","volume":"63","author":"Spriet","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib86","unstructured":"Watt K, Benjamin DK Jr, Cheifetz IM, et al: Pharmacokinetics and safety of fluconazole in infants and children supported with ECMO. Presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, 2011, Chicago, IL"},{"key":"10.1053\/j.semperi.2012.06.003_bib87","first-page":"99","article-title":"Outcome of treatment of candidemia in children whose central catheters were removed or retained","volume":"8","author":"Eppes","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib88","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1542\/peds.106.5.e63","article-title":"Should central venous catheters be removed as soon as candidemia is detected in neonates?","volume":"106","author":"Karlowicz","year":"2000","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib89","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2005-2677","article-title":"The association of third-generation cephalosporin use and invasive candidiasis in extremely low Birth-Weight infants","volume":"118","author":"Cotten","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib90","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib91","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014A prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib92","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/174.3.583","article-title":"Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following Liver transplantation","volume":"174","author":"Lumbreras","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib93","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies","volume":"13","author":"Ninane","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib94","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib95","doi-asserted-by":"crossref","first-page":"R710","DOI":"10.1186\/cc3883","article-title":"The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: A meta-analysis","volume":"9","author":"Ho","year":"2005","journal-title":"Crit Care"},{"key":"10.1053\/j.semperi.2012.06.003_bib96","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: Systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer","author":"Gotzsche","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2012.06.003_bib98","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/46.6.1001","article-title":"Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients","volume":"46","author":"Laverdi\u00e8re","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib99","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Powderly","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01974613","article-title":"Pharmacokinetics of fluconazole in pediatric patients","volume":"13","author":"Brammer","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.semperi.2012.06.003_bib101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/clpt.1993.147","article-title":"Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life","volume":"54","author":"Sax\u00e9n","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semperi.2012.06.003_bib102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1542\/peds.107.2.293","article-title":"Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant","volume":"107","author":"Kicklighter","year":"2001","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib103","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates","volume":"356","author":"Manzoni","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2012.06.003_bib104","first-page":"830","article-title":"Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants","volume":"44","author":"Parikh","year":"2007","journal-title":"Indian Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2005.03.036","article-title":"Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight","volume":"147","author":"Kaufman","year":"2005","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/INF.0b013e318170bb0c","article-title":"Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies","volume":"27","author":"Manzoni","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib107","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.jp.7211570","article-title":"Fluconazole prophylaxis in extremely low birth weight infants: Association with cholestasis","volume":"26","author":"Aghai","year":"2006","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2012.06.003_bib108","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.2004-2227","article-title":"Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: A single-center, 6-year, retrospective cohort study","volume":"117","author":"Manzoni","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib109","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2005.02.020","article-title":"Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants","volume":"147","author":"Bertini","year":"2005","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib110","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1542\/peds.2005-1969","article-title":"Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants","volume":"117","author":"Uko","year":"2006","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.jp.7211914","article-title":"Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure","volume":"28","author":"Weitkamp","year":"2008","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2012.06.003_bib112","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/INF.0b013e3181bf8eb1","article-title":"Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants","volume":"29","author":"Aziz","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.semperi.2012.06.003_bib113","first-page":"1226","article-title":"Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence","volume":"42","author":"Dutta","year":"2005","journal-title":"Indian Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib114","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1136\/adc.2006.094359","article-title":"Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection","volume":"92","author":"McCrossan","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1053\/j.semperi.2012.06.003_bib115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2005.04.016","article-title":"Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit","volume":"147","author":"Healy","year":"2005","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib116","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2007-1130","article-title":"Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida Species","volume":"121","author":"Healy","year":"2008","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2012.06.003_bib117","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/AAC.01053-05","article-title":"Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: Fluconazole and Candida albicans","volume":"50","author":"Andes","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semperi.2012.06.003_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003850.pub3","article-title":"Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants","author":"Clerihew","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2012.06.003_bib119","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpeds.2010.11.002","article-title":"Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age","volume":"158","author":"Kaufman","year":"2011","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2012.06.003_bib120","series-title":"Fluconazole prophylaxis for the prevention of candidiasis in infants less than 750 grams birthweight [internet]","author":"Kaufman","year":"2011"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000512000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000512000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:53:37Z","timestamp":1758938017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000512000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0146000512000717"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2012.06.003","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and Prophylaxis of Invasive Candidiasis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2012.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}